Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)
This study is currently recruiting participants.
Verified April 2013 by National Institute of Allergy and Infectious Diseases (NIAID)
Study NCT01253538   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on December 1, 2010.   Last Updated on April 25, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV
Interventions listed in this trial
Zidovudine (ZDV)
Nevirapine (NVP)
Lamivudine-Zidovudine (3TC-ZDV)
Lopinavir-ritonavir (LPV-RTV)
Additional drug interventions recognized in this trial
Emtricitabine
Lamivudine
Lamivudine, zidovudine drug combination
Lopinavir
Nevirapine
Ritonavir
Tenofovir
Tenofovir disoproxil
Zidovudine
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antimetabolites
Antiviral Agents
Enzyme Inhibitors
HIV Protease Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Protease Inhibitors
Reverse Transcriptase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services